SeaStar Medical
ICU | NASDAQ
$3.47
-$0.11 (-3.07%)
Sep 22, 2026, 11:31 AM ET · Market open
Market Data
Market Cap $10.16M
Enterprise Value $3.2M
Beta -1.03
Average Volume 83.45K
Shares Outstanding (Diluted) 4.08M
Shares Change YoY 133.31%
Institutional Ownership 3.22%
Exchange NASDAQ
ISIN US81256L3024
Price Performance
Price Change 1M 7.2%
Price Change 3M 3.2%
Price Change 6M 57.0%
Price Change YTD 36.1%
Price Change 1Y -64.2%
Price Change 3Y -92.1%
Price Change 5Y -99.9%
1M CAGR (ann.) 9.2%
1Y CAGR (ann.) -60.2%
5Y CAGR (ann.) N/A
All-Time CAGR -80.8%
Valuation
PE Ratio -0.92
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.02
PS Ratio 5.93
Forward PS 3.40
PB Ratio 2.36
P/FCF Ratio -0.74
P/Adj. FCF Ratio -0.72
P/OCF Ratio -1.07
EV/Sales 1.87
EV/EBIT -0.23
EV/EBITDA -0.23
EV/FCF -0.23
Earnings Yield -109.2%
FCF Yield -134.8%
Adj. FCF Yield -138.2%
Financial Health
Net Cash $6.96M
Total Debt $0
Cash & Short-Term Investments $6.96M
Total Assets $8.65M
Current Ratio 1.89
Quick Ratio 1.87
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage -518.11
Altman Z-Score -28.82
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 92.6%
Operating Profit Margin -816.6%
EBITDA Margin -797.5%
Net Profit Margin -795.5%
FCF Margin -799.4%
Adj. FCF Margin -819.9%
SBC / Revenue 20.6%
SBC Impact (per share) -2.6%
Returns
Return on Assets -157.6%
Return on Equity -162.8%
Return on Invested Capital -325.6%
Return on Capital Employed -325.6%
Return on Tangible Assets -157.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 103.7%
Revenue CAGR 5Y 84.5%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 128.2%
EPS CAGR 5Y 40.6%
EPS CAGR 10Y N/A
FCF CAGR 3Y -5.7%
FCF CAGR 5Y -16.6%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 1
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.95
EPS Growth Est (next Q) -26.9%
Revenue Est (next Q) $500K
Revenue Growth Est (next Q) 173.2%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $8
Price Target Upside 123.5%
Cash Flow
Operating Cash Flow $-13.69M
Free Cash Flow $-13.69M
Adj. Free Cash Flow $-14.05M
FCF Per Share -$3.35
OCF Per Share -$3.35
OCF/S Ratio -799.4%
Income Statement
Revenue $1.71M
Gross Profit $1.59M
Operating Income $-13.99M
EBITDA $-13.66M
Net Income $-13.63M
EPS (Diluted) -$3.91
Revenue / Employee $95.17K
Profit / Employee $-757.06K
Employees 18
Add to Watchlist
Select watchlists to add or remove ICU